HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qin Chen Selected Research

Ciclopirox (Loprox)

1/2022Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells.
9/2020Correction: Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.
1/2020Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qin Chen Research Topics

Disease

73Neoplasms (Cancer)
06/2022 - 04/2004
16Infections
09/2022 - 12/2006
12Inflammation (Inflammations)
01/2022 - 01/2014
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 04/2010
11Neoplasm Metastasis (Metastasis)
11/2021 - 07/2002
9Breast Neoplasms (Breast Cancer)
01/2022 - 11/2009
9Carcinogenesis
07/2020 - 07/2002
7Body Weight (Weight, Body)
01/2022 - 10/2011
7Dementia (Dementias)
01/2022 - 05/2002
7Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 07/2018
7Parkinson Disease (Parkinson's Disease)
01/2019 - 02/2005
6Alzheimer Disease (Alzheimer's Disease)
04/2022 - 03/2015
6Glaucoma
02/2022 - 01/2013
6Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 08/2010
6Hyperlipidemias (Hyperlipidemia)
10/2017 - 08/2009
5Hepatocellular Carcinoma (Hepatoma)
07/2021 - 07/2002
5Epilepsy (Aura)
01/2021 - 12/2005
5Hypoxia (Hypoxemia)
01/2021 - 10/2009
4Pneumonia (Pneumonitis)
01/2022 - 01/2017
4Liver Neoplasms (Liver Cancer)
05/2021 - 06/2007
4Leukemia
12/2020 - 01/2006
4Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 07/2008
3Wounds and Injuries (Trauma)
09/2022 - 01/2021
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 08/2007
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2016
3Obesity
01/2022 - 06/2018
3Critical Illness (Critically Ill)
01/2022 - 01/2021
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 06/2020
3COVID-19
01/2022 - 10/2020
3Disease Progression
01/2022 - 11/2017
3Atrophy
01/2022 - 01/2019
3Pain (Aches)
07/2021 - 01/2020
3Carcinoma (Carcinomatosis)
04/2021 - 01/2018
3Parkinsonian Disorders (Parkinsonism)
01/2021 - 05/2002
3Ganglion Cysts (Ganglion)
01/2021 - 11/2010
3Hemorrhage
01/2021 - 12/2006
3Cataract (Cataracts)
05/2020 - 03/2016
3Adenocarcinoma
01/2020 - 01/2012
3Urinary Bladder Neoplasms (Bladder Cancer)
05/2019 - 09/2013
3Constipation
01/2019 - 06/2014
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 08/2010
3Stroke (Strokes)
01/2019 - 01/2016
3Ischemia
01/2019 - 06/2007
3Asthma (Bronchial Asthma)
04/2018 - 04/2003
3Fibrosis (Cirrhosis)
12/2017 - 12/2015
3Melanoma (Melanoma, Malignant)
01/2015 - 04/2010
3Chromosome Aberrations (Chromosome Abnormalities)
06/2013 - 10/2011

Drug/Important Bio-Agent (IBA)

20Pharmaceutical PreparationsIBA
07/2022 - 12/2005
19Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
16Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2006
9LipidsIBA
01/2022 - 11/2012
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2022 - 06/2007
8Therapeutic UsesIBA
09/2022 - 10/2006
7Long Noncoding RNAIBA
01/2022 - 08/2014
7MicroRNAs (MicroRNA)IBA
08/2020 - 07/2015
6Glucose (Dextrose)FDA LinkGeneric
11/2021 - 01/2016
6Transcription Factors (Transcription Factor)IBA
07/2021 - 01/2012
6Retinaldehyde (Retinal)IBA
01/2021 - 11/2010
5CytokinesIBA
01/2022 - 01/2017
5Phosphotransferases (Kinase)IBA
01/2018 - 06/2007
4CurcuminIBA
01/2022 - 08/2015
4Oxygen (Dioxygen)IBA
01/2022 - 07/2015
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2017
4Cholinergic Agents (Cholinergics)IBA
01/2022 - 06/2005
4IronIBA
01/2022 - 07/2008
4ProdrugsIBA
10/2020 - 01/2018
4Antiviral Agents (Antivirals)IBA
10/2020 - 10/2014
4RNA (Ribonucleic Acid)IBA
01/2020 - 11/2018
4Peptides (Polypeptides)IBA
01/2019 - 05/2005
4AntigensIBA
05/2014 - 04/2010
3HydrogelsIBA
09/2022 - 08/2006
3Anti-Bacterial Agents (Antibiotics)IBA
09/2022 - 10/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 07/2008
3Ciclopirox (Loprox)FDA LinkGeneric
01/2022 - 01/2020
3Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 01/2014
3Neutralizing AntibodiesIBA
07/2021 - 01/2008
3Amyloid (Amyloid Fibrils)IBA
01/2021 - 03/2015
3Messenger RNA (mRNA)IBA
01/2021 - 04/2013
3Hemoglobins (Hemoglobin)IBA
01/2021 - 04/2013
3Neuroprotective AgentsIBA
01/2020 - 04/2017
3Insulin (Novolin)FDA Link
01/2020 - 11/2011
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2019 - 10/2012
3SolutionsIBA
01/2019 - 10/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2017 - 01/2016
3SodiumIBA
04/2017 - 01/2016
3artenimol (dihydroartemisinin)IBA
05/2016 - 07/2008
3EnzymesIBA
08/2015 - 06/2007
3Glutathione PeroxidaseIBA
01/2015 - 01/2015
3GTP Phosphohydrolases (GTPases)IBA
06/2011 - 08/2010
3Focal Adhesion Protein-Tyrosine KinasesIBA
06/2011 - 08/2010

Therapy/Procedure

46Therapeutics
06/2022 - 02/2005
11Drug Therapy (Chemotherapy)
01/2022 - 01/2012
5Electroacupuncture
07/2021 - 01/2014
5Radiotherapy
01/2021 - 01/2012
3Immunotherapy
06/2022 - 03/2019
3Lasers (Laser)
02/2021 - 01/2019
3Ligation
01/2019 - 06/2007
3Aftercare (After-Treatment)
01/2019 - 10/2006
3Trabeculectomy (Trabeculoplasty)
01/2017 - 05/2007
3Oral Administration
09/2016 - 04/2013